Mentice Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Public

  • Employees
  • 111

Employees

  • Stock Symbol
  • MNTC

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $1.63
  • (As of Tuesday Closing)

Mentice General Information

Description

Mentice AB is a provider of software and hardware simulation solutions for image guided interventional therapies, offering proficiency based simulation solutions that help healthcare professionals acquire, retain, and enhance procedural skills, improving productivity and outcomes. Its solutions are scientifically validated and developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are covered. Mentice operates in two segments: Medical Device Industry (MDI), providing end-to-end solutions supporting development and launch of interventional therapies, and Healthcare Systems (HCS). Product areas include Mentice VIST, Physical Sim, Mentice Live, and Ankyras. It operates in EMEA, APAC, and the Americas.

Contact Information

Website
www.mentice.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Odinsgatan 10
  • 411 03 Gothenburg
  • Sweden
+46
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Stock Exchange
STO
Vertical(s)
Corporate Office
  • Odinsgatan 10
  • 411 03 Gothenburg
  • Sweden
+46

Mentice Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mentice Stock Performance

As of 17-Nov-2026, Mentice’s stock price is $1.63. Its current market cap is $45.9M with 28.1M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.63 $1.68 $1.25 - $1.99 $45.9M 28.1M 11.7K -$0.07

Mentice Financials Summary

As of 30-Sep-2026, Mentice has a trailing 12-month revenue of $32.5M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 37,452 38,363 55,430 115,707
Revenue 32,478 28,407 27,452 25,742
EBITDA 1,527 148 1,232 2,643
Net Income (1,979) (3,291) (1,742) (265)
Total Assets 30,266 33,908 29,356 32,272
Total Debt 1,407 1,828 828 956
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Mentice Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Mentice‘s full profile, request access.

Request a free trial

Mentice Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Mentice AB is a provider of software and hardware simulation solutions for image guided interventional therapies, offeri
Monitoring Equipment
Gothenburg, Sweden
111 As of 2026

Miami, FL
 

Latham, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mentice Competitors (3)

One of Mentice’s 3 competitors is Gaumard, a Corporation company based in Miami, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gaumard Corporation Miami, FL
Angiodynamics Corporation Latham, NY
Biotronik Corporate Backed or Acquired Berlin, Germany
You’re viewing 3 of 3 competitors. Get the full list »

Mentice Patents

Mentice Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4381412-A1 Devices, systems, and methods for 3d printing of vasculature Pending 02-Aug-2021
EP-4377942-A1 System for advanced physician training and patient specific rehearsals Pending 25-Jul-2021
EP-4330990-A1 Decision support tool for endovascular procedures Pending 26-Apr-2021
US-20220338929-A1 Decision support tool for endovascular procedures Pending 26-Apr-2021
WO-2022229066-A1 Decision support tool for endovascular procedures Inactive 26-Apr-2021 G16H20/40
To view Mentice’s complete patent history, request access »

Mentice Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mentice Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Mentice‘s full profile, request access.

Request a free trial

Mentice Acquisitions (5)

Mentice’s most recent deal was a Merger/Acquisition with Biomodex for . The deal was made on 11-Dec-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Biomodex 11-Dec-2023 Merger/Acquisition Other Devices and Supplies
Ankyras 30-Jun-2022 Merger/Acquisition Application Software
EQIP (Medical Records Systems) 08-Oct-2020 Merger/Acquisition Medical Records Systems
Vascular Simulations 01-Oct-2020 Merger/Acquisition Other Healthcare Technology Systems
Medical Simulation Corporation (Medical Products Division) 20-Dec-2017 Merger/Acquisition Other Devices and Supplies
To view Mentice’s complete acquisitions history, request access »

Mentice ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Mentice’s complete esg history, request access »

Mentice Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Biomodex Paris, France 2015

Mentice FAQs

  • When was Mentice founded?

    Mentice was founded in 1998.

  • Where is Mentice headquartered?

    Mentice is headquartered in Gothenburg, Sweden.

  • What is the size of Mentice?

    Mentice has 111 total employees.

  • What industry is Mentice in?

    Mentice’s primary industry is Monitoring Equipment.

  • Is Mentice a private or public company?

    Mentice is a Public company.

  • What is Mentice’s stock symbol?

    The ticker symbol for Mentice is MNTC.

  • What is the current stock price of Mentice?

    As of 17-Nov-2026 the stock price of Mentice is $1.63.

  • What is the current market cap of Mentice?

    The current market capitalization of Mentice is $45.9M.

  • What is Mentice’s current revenue?

    The trailing twelve month revenue for Mentice is $32.5M.

  • Who are Mentice’s competitors?

    Gaumard, Angiodynamics, and Biotronik are competitors of Mentice.

  • What is Mentice’s annual earnings per share (EPS)?

    Mentice’s EPS for 12 months was -$0.07.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process